1. Bristol-Myers Urges Shareholders in Open Letter to Support $74 Billion Celgene Deal Amid Resistance

    Bristol-Myers Urges Shareholders in Open Letter to Support $74 Billion Celgene Deal Amid Resistance

    The company said in an open letter to shareholders, its board of directors are "confident" the drugmakers acquisition of Celgene is the best path forward...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. The board argued the Celgene transaction will ensure the company's
    2. We undertook a robust and comprehensive review of our core business and strategic expansion opportunities potentially available to the company and identified the Celgene acquisition as the most attractive opportunity for shareholder value creation.
  3. Topics Mentioned

  4. Authors